Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VEGFR2 (FLK1/KDR) Antibody (C-term) Blocking peptide | Login | VEGFR2 (FLK1/KDR) Antibody (C-term) Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| PTHLH Antibody (Center) Blocking Peptide | Login | PTHLH Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| IGF1 Receptor (IGF1R) Antibody (N-term) Blocking peptide | Login | IGF1 Receptor (IGF1R) Antibody (N-term) Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| IGF1 Receptor (IGF1R) Antibody (C-term) Blocking peptide | Login | IGF1 Receptor (IGF1R) Antibody (C-term) Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| NQO1 Antibody (C-term) Blocking Peptide | Login | NQO1 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| NQO1 Antibody (Center) Blocking Peptide | Login | NQO1 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PTTG1 Antibody (N-term) Blocking Peptide | Login | PTTG1 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MAF Antibody (C-term) Blocking Peptide | Login | MAF Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PMS2 Antibody (C-term) Blocking Peptide | Login | PMS2 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PMS2 Antibody (Center) Blocking Peptide | Login | PMS2 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| CDC2 (CDK1) Blocking Peptide (N-term) | Login | CDC2 (CDK1) Blocking Peptide (N-term) | ||||||||||||||||
|
||||||||||||||||||
| NUP98 Antibody (C-term) Blocking Peptide | Login | NUP98 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| NTRK3 Antibody (C-term) Blocking Peptide | Login | NTRK3 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| POLR2A Antibody (N-term) Blocking Peptide | Login | POLR2A Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PRKACA Antibody (N-term K82) Blocking Peptide | Login | PRKACA Antibody (N-term K82) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PTPN11 Antibody (C-term) Blocking Peptide | Login | PTPN11 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AURKA Antibody (C-term) Blocking Peptide | Login | AURKA Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| GNAS Antibody (Center) Blocking Peptide | Login | GNAS Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PAX8 Antibody (Center) Blocking Peptide | Login | PAX8 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| HLA-DRB1 Antibody (N-term) Blocking Peptide | Login | HLA-DRB1 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| CALR Antibody (Center) Blocking Peptide | Login | CALR Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| CBFB Antibody (Center) Blocking Peptide | Login | CBFB Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| GAB2 Antibody (N-term) Blocking Peptide | Login | GAB2 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| XRCC3 Antibody (Center) Blocking Peptide | Login | XRCC3 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| BICC1 Antibody (N-term) Blocking Peptide | Login | BICC1 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||


